Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Here's How Much You'd Have If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago
12:30pm, Monday, 12'th Sep 2022 Zacks Investment Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks.com featured highlights include Tsakos Energy, AVEO Pharmaceuticals and Catalyst Pharmaceuticals
09:42am, Monday, 12'th Sep 2022 Zacks Investment Research
Tsakos Energy, AVEO Pharmaceuticals and Catalyst Pharmaceuticals have been highlighted in this Screen of The Week article.
Biotech, Tanker Stocks Hit New Highs, Top Bullish Patterns
01:45pm, Friday, 09'th Sep 2022
Both are in buy zones after topping follow-on patterns. The post Biotech, Tanker Stocks Hit New Highs, Top Bullish Patterns appeared first on Investor's Business Daily.
Why Catalyst Pharmaceuticals Stock Marched Higher This Week
12:45pm, Friday, 09'th Sep 2022 The Motley Fool
This supercharged growth stock posted a new all-time high this week.
Why Catalyst Pharmaceuticals Stock Marched Higher This Week
08:45am, Friday, 09'th Sep 2022
This supercharged growth stock posted a new all-time high this week.
Buy These 3 Top Breakout Stocks Now for Superb Returns
08:17am, Friday, 09'th Sep 2022
Tsakos Energy Navigation (TNP), AVEO Pharmaceuticals (AVEO) and Catalyst Pharmaceuticals (CPRX) have been selected as the breakout stocks for today.
Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
08:03am, Friday, 09'th Sep 2022
CORAL GABLES, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
Catalyst (CPRX) Up 13.3% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 08'th Sep 2022
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst Pharmaceutical (CPRX) Just Reclaimed the 20-Day Moving Average
11:17am, Thursday, 08'th Sep 2022
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Got $1,500? Buy These 2 Surging Growth Stocks
10:37am, Friday, 02'nd Sep 2022
Their recent successes with commercializing medicines are paying off.
Catalyst Pharmaceuticals' CEO Wants In On The Biotech Buying Spree
08:00am, Thursday, 01'st Sep 2022
Catalyst Pharmaceuticals is now looking for its second act after launching a LEMS treatment. Could CPRX stock investors see a buyout?
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
03:26pm, Wednesday, 31'st Aug 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
3 Reasons Why Catalyst (CPRX) Is a Great Growth Stock
02:18pm, Friday, 26'th Aug 2022
Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.
Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy
01:33pm, Friday, 26'th Aug 2022
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Catalyst Pharmaceuticals (CPRX) Q2 Earnings Top, Revenues Up
06:30pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Catalyst (CPRX) beat earnings and sales estimate in second-quarter 2022 earnings. Consequently, the stock surges.
